← Back to Search

Sleep-Based Memory Reactivation for PTSD Symptoms

N/A
Recruiting
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
---
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 15 minutes before sleep onset and approximately 15 minutes after sleep offset within the same experimental session
Awards & highlights

Study Summary

This trial is testing whether sleep can be used to weaken non-adaptive memories, which may be helpful for people with memory-related symptoms of disorders like PTSD.

Who is the study for?
This trial is for individuals interested in participating in a study that explores how sleep can affect memory suppression and enhancement. Participants should be willing to undergo EEG monitoring and engage in tasks involving odors and sounds associated with memories.Check my eligibility
What is being tested?
The study tests if targeted memory reactivation using odors and sounds during sleep can weaken or strengthen specific memories. It involves learning tasks, followed by a nap where selected cues are presented, to see how they influence memory recall.See study design
What are the potential side effects?
Since this trial involves non-invasive techniques like exposure to odors and sounds while sleeping, there are minimal expected side effects. However, individual reactions to the sensory stimuli cannot be fully predicted.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 15 minutes before sleep onset and approximately 15 minutes after sleep offset within the same experimental session
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 15 minutes before sleep onset and approximately 15 minutes after sleep offset within the same experimental session for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in error rates between pre- and post-sleep for the different conditions
Modulation of EEG spectral power following sound/odor presentation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental groupExperimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Targeted memory reactivation (sounds)
2021
N/A
~70

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,589 Previous Clinical Trials
917,088 Total Patients Enrolled
6 Trials studying Sleep
598 Patients Enrolled for Sleep

Media Library

Targeted memory reactivation (sounds) Clinical Trial Eligibility Overview. Trial Name: NCT04702750 — N/A
Sleep Research Study Groups: Experimental group
Sleep Clinical Trial 2023: Targeted memory reactivation (sounds) Highlights & Side Effects. Trial Name: NCT04702750 — N/A
Targeted memory reactivation (sounds) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04702750 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~8 spots leftby Nov 2024